carbapenems has been researched along with malondialdehyde in 1 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 27,849 | 1,405 | 13,922 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamis, G; Christodoulou, S; Chrysanthakopoulou, M; Giamarellos-Bourboulis, EJ; Gkizeli, K; Karampela, I; Karlis, G; Kyriazopoulou, E; Safarika, A; Veliki, N | 1 |
1 other study(ies) available for carbapenems and malondialdehyde
Article | Year |
---|---|
Lipid peroxidation in Gram-negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Antioxidants; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipid Peroxidation; Male; Malondialdehyde; Neutrophils; Prospective Studies; Risk Factors; Shock, Septic | 2017 |